FIT as a Comparator for Evaluating the Effectiveness of New Non-invasive CRC Screening Test
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Fecal immunochemical tests (FIT) are effective for colorectal cancer (CRC) screening and mortality reduction. This paper explains why FIT is the best comparator for evaluating new non-invasive CRC screening tests.
Area Of Science
- Gastroenterology
- Oncology
- Preventive Medicine
Background
- Guaiac-based fecal occult blood tests (gFOBT), sigmoidoscopy, and colonoscopy reduce colorectal cancer (CRC) risk and mortality.
- Fecal immunochemical test (FIT) effectiveness is supported by comparative analyses with gFOBT and extensive data on its sensitivity and specificity.
- FIT has largely replaced gFOBT in global organized screening programs.
Purpose Of The Study
- To provide an overview of the evidence and rationale for using FIT as a comparator in evaluating new non-invasive colorectal cancer screening tests.
- To guide the selection of cut-off values for new tests and document potential sensitivity gains through direct comparison with FIT.
- To outline methods for evaluating new tests, including cross-sectional and multiple-round prospective comparisons.
Main Methods
- Utilizing FIT as a comparator for evaluating new non-invasive tests based on test performance and intermediate outcomes like interval cancer rates.
- Employing paired or parallel designs in cross-sectional single-round screening evaluations for direct participation rate comparisons.
- Conducting multiple-round prospective comparisons to assess the impact on CRC risk, precancerous lesions, and late-stage cancer incidence reduction.
Main Results
- FIT is an efficient comparator for assessing new non-invasive tests' effectiveness and performance.
- Direct comparison with FIT aids in selecting optimal cut-off values and maximizing sensitivity gains.
- Prospective comparisons using FIT as a benchmark can demonstrate reductions in CRC incidence and mortality proxies.
Conclusions
- FIT is the preferred comparator for evaluating new non-invasive colorectal cancer screening tests.
- Using FIT allows for efficient assessment of test accuracy, participation rates, and potential impact on CRC outcomes.
- The methodology outlined supports the development and implementation of improved CRC screening strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...